Long intergenic non-protein coding RNA 3022 (LINC03022)

Long intergenic non-protein coding RNA 3022 (LINC03022) is a human gene that encodes a long non-coding RNA (lncRNA), meaning it is an RNA molecule of greater than 200 nucleotides that does not encode a protein but may have regulatory roles in the genome[1][5][7][10]. It is located in intergenic regions and categorized as a non-coding transcript[3][5][7][11]. No direct literature supports its role as a pharmacological therapeutic target, receptor, enzyme, transporter, or known molecular drug target as of the current knowledge. Its expression and function are poorly characterized; however, by analogy to similar lncRNAs in human cancers, such molecules can participate in gene regulation and may be differentially expressed in disease, but there is currently no validated role or direct targeting evidence for LINC03022 in clinical or preclinical settings[10]. There is no evidence of drug interactions, biomarker utility, or specific safety concerns for this RNA. Notes: - LINC03022 is not a protein, receptor, enzyme, transporter, transcription factor, or classic therapeutic target, and there is no known mechanism of action for drug targeting or clinical use. - The gene is valid, not misspelled, and has recognized IDs (HGNC:56151, NCBI Gene: 101929191, Ensembl: ENSG00000253641)[5][10]. - There are no approved or experimental drugs, biomarkers, or established disease mechanisms associated directly with LINC03022. - Most available data consists of sequence and basic expression annotation; functional or mechanistic data are lacking. Based on authoritative databases and current scientific literature, LINC03022 is classified as a lncRNA gene with no established target or therapeutic role as of September 2025.

Other names

LINCR-0001AC104964.1